Cancer immunoresistance may be partially due to loss of a well-known tumor suppressor gene, according to new research led by Andrew T. Parsa, MD, PhD, assistant professor of neurological surgery at the University of California, San Francisco. The findings are reported today (December 10) online and are scheduled to appear in the January issue of Nature Medicine.
